Federal Circuit Reverses Summary Judgment of Invalidity for Patent Covering Prescription Sorting Machines

Aug 30, 2016

Reading Time : 1 min

The patent at issue, U.S. Patent No. 6,910,601, discussed a “collating unit,” which corrals prescription containers after they have been filled with a prescription by an automatic dispensing system. The asserted claims were directed to such a collating unit, but did not recite a limitation for how the containers were sorted and stored. The district court determined that the ’601 patent disclosed only a collating unit that used patient-specific information for sorting and storing the containers. Citing Gentry Gallery and ICU Medical, the district court ruled that the claims were invalid for being broader than the disclosure.

The Federal Circuit disagreed. That court drew a distinction between the disclosures in the ’601 patent and the patents involved in Gentry Gallery and ICU Medical. In Gentry Gallery and ICU Medical, “the specifications clearly limited the scope of the claims in ways that the claims clearly did not.” But, even though “much of the ’601 patent’s specification focuse[d] on” a type of embodiment using patient-specific information, the Federal Circuit held that the ’601 patent was not so limited. Rather, the specification disclosed other problems which the invention could solve by using different types of information, such as the type of medication or the date the prescription is filled. Additionally, the Federal Circuit found support in the originally-filed claims. As part of the disclosure, these claims supported the broader invention because they, too, were not limited to embodiments relying on patient-specific information.

ScriptPro LLC v. Innovation Assocs., Inc., No. 2015-1565, 2016 WL 4269920 (Fed. Cir. Aug. 15, 2016).

[Moore (opinion), Taranto, and Hughes]

Share This Insight

Previous Entries

IP Newsflash

September 23, 2024

The Director of the USPTO initiated sua sponte review of a PTAB panel’s decision to impose sanctions based on patentee’s conduct during IPR proceedings. The PTAB cancelled all of patentee’s claims, including those not unpatentable on the merits, after finding that patentee deliberately withheld data relevant to the patentability of the claims at issue. In her review, the Director addressed which regulations are implicated upon a party’s misconduct during AIA proceedings and addressed whether entry of judgment in the trial was an appropriate sanction.

...

Read More

IP Newsflash

September 18, 2024

The Western District of Texas granted a motion to stay a patent infringement lawsuit pending inter partes review not only because doing so would simplify the issues in the still-early litigation and reduce the burden on the parties, but also because the non-moving party failed to diligently file its lawsuit despite a protracted negotiations period.

...

Read More

IP Newsflash

September 16, 2024

The Federal Circuit dismissed an appeal from an inter partes review (“IPR”) final written decision for lack of standing where it found the appellant failed to provide evidence sufficient to show it suffered an injury in fact.

...

Read More

IP Newsflash

September 9, 2024

The Federal Circuit recently affirmed an ITC holding that the AIA’s § 102 on-sale bar applies to the sale of a product made according to a secret process when that sale occurs more than one year before the patent’s effective filing date. In so doing, the court confirmed that, despite changes to the text of § 102, the AIA did not undo long-settled pre-AIA precedent that the on-sale bar applies when, before the critical date, a party sells products secretly made using a patented process.

...

Read More

IP Newsflash

September 5, 2024

The Patent Trial and Appeal Board exercised its discretion under General Plastic to deny institution of a follow-on petitioner’s request for inter partes review despite determining that the petitioner did not have a “significant relationship” with a previous petitioner that had challenged the same patent. The PTO Director vacated the board’s decision, holding that “where . . . the first and second petitioners are neither the same party, nor possess a significant relationship . . . General Plastic factor one necessarily outweighs the other . . . factors.”

...

Read More

IP Newsflash

August 28, 2024

The Patent Trial and Appeal Board has denied institution of an inter partes review for a design patent in part because the petitioner failed to show that three asserted references qualified as prior art. Specifically, the PTAB ruled that images of a boot design taken from a website after the critical date, coupled with evidence that the design was on sale before the critical date, was insufficient to establish the design as prior art. Critical to the PTAB’s determination was the fact that webpages are “dynamic” and change over time, rendering images taken from the current webpage insufficient to establish prior disclosure.

...

Read More

IP Newsflash

August 21, 2024

The Federal Circuit dismissed an appeal of a final written decision in an IPR based on issue preclusion where a district court had dismissed a complaint finding the patent claims subject-matter ineligible. The patentee had filed a second amended complaint, but then voluntarily dismissed the case without asking the district court to vacate its prior invalidity ruling, which it also never appealed. The Federal Circuit held that the initial invalidity order was interlocutory when issued but merged with the voluntary dismissal with prejudice, making the invalidity determination final and the present appeal moot.

...

Read More

IP Newsflash

August 21, 2024

The Patent Trial and Appeal Board denied institution of an inter partes review petition because a prior art patent figure did not provide exact dimensions, and therefore could not meet the relevant claim limitation.  On review from the denied institution, the Director explained that a drawing may be relied upon for what it clearly shows, vacating and remanding for a determination of whether the reference is clear on its face or reasonably would have suggested the limitation in view of the supporting expert testimony.

...

Read More

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.